CA2080460C - Myocardial ischemia monitor and related method - Google Patents
Myocardial ischemia monitor and related methodInfo
- Publication number
- CA2080460C CA2080460C CA002080460A CA2080460A CA2080460C CA 2080460 C CA2080460 C CA 2080460C CA 002080460 A CA002080460 A CA 002080460A CA 2080460 A CA2080460 A CA 2080460A CA 2080460 C CA2080460 C CA 2080460C
- Authority
- CA
- Canada
- Prior art keywords
- electrogram
- voltage
- patient
- skin
- electrode
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/6852—Catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0031—Implanted circuitry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/25—Bioelectric electrodes therefor
- A61B5/279—Bioelectric electrodes therefor specially adapted for particular uses
- A61B5/28—Bioelectric electrodes therefor specially adapted for particular uses for electrocardiography [ECG]
- A61B5/283—Invasive
- A61B5/287—Holders for multiple electrodes, e.g. electrode catheters for electrophysiological study [EPS]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Surgery (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- Pathology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Computer Networks & Wireless Communication (AREA)
- Physiology (AREA)
- Cardiology (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
- Electrotherapy Devices (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Window Of Vehicle (AREA)
Abstract
An implantable device assists in the diagnosis of myocardial ischemia of a human heart and includes a plurality of electrodes and a like plurality of sense amplifiers for generating an electrogram for each of the electrodes. A digital to analog converter reads the voltage magnitudes of the electrogram ST segments which are then stored in a memory. An implantable receiver/transmitter is arranged to transmit the magnitudes of the electrogram ST segments to a nonimplanted external receiver.
Description
~YOCARD~ T~ J~l.~R AND RELA~ED
R2~ RO~ND OF T}{E lNVI~ ON
The present invention generally relates to an apparatus and method for a~sisting in the diagnosi~ of myocardial ischemia of a human heart. The present invention is more particularly directed to an apparatus and method for providing data related to the activity of the human heart, wherein the apparatus is fully implantable beneath the skin of a patient and wherein the data provided may be utilized to advantage for ;
dete~ ining the presence or absence of ischemia in the human heart.
Patients who suffer what i.5 commonly called a heart attack most often experience an episode of myocardial infarction. Myocardial in~arction is a necrosis of cardiac tissue brought on by a reduction in blood ~low to the infarcted area caused by eith~r an obstruction in an artery or a thromhus in the artery.
Patients who have suffered from myocardial infarction ~re generally treated with drugs or surgery to open the artery or undergo coronary artery bypass graft surgery to bypass the artery section having the obstruction or thrombus.
Each of the above-mentioned therapeutic techniques ~s effecti-ie in reestablishing blood flow through the effected artery. However, for each therapy, there is a percentage of patients that experience restenosis (reclosure of the artery) after therapy.
Restenosis is largely an unpredictable event and the time :: ~ .,' ' : , :~
::
, ,, : ~ i : ,. :
R2~ RO~ND OF T}{E lNVI~ ON
The present invention generally relates to an apparatus and method for a~sisting in the diagnosi~ of myocardial ischemia of a human heart. The present invention is more particularly directed to an apparatus and method for providing data related to the activity of the human heart, wherein the apparatus is fully implantable beneath the skin of a patient and wherein the data provided may be utilized to advantage for ;
dete~ ining the presence or absence of ischemia in the human heart.
Patients who suffer what i.5 commonly called a heart attack most often experience an episode of myocardial infarction. Myocardial in~arction is a necrosis of cardiac tissue brought on by a reduction in blood ~low to the infarcted area caused by eith~r an obstruction in an artery or a thromhus in the artery.
Patients who have suffered from myocardial infarction ~re generally treated with drugs or surgery to open the artery or undergo coronary artery bypass graft surgery to bypass the artery section having the obstruction or thrombus.
Each of the above-mentioned therapeutic techniques ~s effecti-ie in reestablishing blood flow through the effected artery. However, for each therapy, there is a percentage of patients that experience restenosis (reclosure of the artery) after therapy.
Restenosis is largely an unpredictable event and the time :: ~ .,' ' : , :~
::
, ,, : ~ i : ,. :
- 2 ~ 6~
required for the reclosure to occur may range from a matter of hours to years.
To mo~itor patients who have suffered from myocardial infarction, physicians may rely upon periodic ECGs (electrocardiograms) which generally require as many as ten leads to be attach~d to the patient. In addition, a~ter the ECG, physicians then generally require the patient to take a stress test wherein the patient is caused to run on a tread mill until the patient is essentially exhausted to stress the heart. During and a~ter the tread mill exercise the twelve lead is used to determine if the heart continues to receive adequate blood supply while under the stress conditions.
Obviously such monitoring is inconvenient to the patient.
Physicians may also rely upon Holtor monitoring recordings which may last from 24 to 48 hours. These additional monitoring techniques are equally as inconvenient and in addition, are also annoying. Since all of these monitoring techniques can only be a~r1n;stered periodically at best as a practical matter, and because restenosis and thus future episodes of myocardial infarction are unpredictable events, all too often, a restenosis problem is not detected until the patient experiences pain or suffers an episode of myocardial infarction. Unfortunately, research has shown th~t pain i~ not a reliable indicator of ischemia. ;-From the foregoing, it can been seen that there is a need in the art for a new and improved monitor and method for monitoring patients who have suffered myocardial ischemia and thus may have a potential restenosis problem. The present invention provides such an apparatus and method because the apparatus is fully implantable beneath ~he skin of the patient and includes electrodes which are arranged to make electrical contact with the heart by, for example, being attached to or near the heart and to monitor heart activity in the form of an electrogram f or each ~lectrode. More particularly, the monitor of the present invention, monitors the ',; ~ ',.
required for the reclosure to occur may range from a matter of hours to years.
To mo~itor patients who have suffered from myocardial infarction, physicians may rely upon periodic ECGs (electrocardiograms) which generally require as many as ten leads to be attach~d to the patient. In addition, a~ter the ECG, physicians then generally require the patient to take a stress test wherein the patient is caused to run on a tread mill until the patient is essentially exhausted to stress the heart. During and a~ter the tread mill exercise the twelve lead is used to determine if the heart continues to receive adequate blood supply while under the stress conditions.
Obviously such monitoring is inconvenient to the patient.
Physicians may also rely upon Holtor monitoring recordings which may last from 24 to 48 hours. These additional monitoring techniques are equally as inconvenient and in addition, are also annoying. Since all of these monitoring techniques can only be a~r1n;stered periodically at best as a practical matter, and because restenosis and thus future episodes of myocardial infarction are unpredictable events, all too often, a restenosis problem is not detected until the patient experiences pain or suffers an episode of myocardial infarction. Unfortunately, research has shown th~t pain i~ not a reliable indicator of ischemia. ;-From the foregoing, it can been seen that there is a need in the art for a new and improved monitor and method for monitoring patients who have suffered myocardial ischemia and thus may have a potential restenosis problem. The present invention provides such an apparatus and method because the apparatus is fully implantable beneath ~he skin of the patient and includes electrodes which are arranged to make electrical contact with the heart by, for example, being attached to or near the heart and to monitor heart activity in the form of an electrogram f or each ~lectrode. More particularly, the monitor of the present invention, monitors the ',; ~ ',.
- 3 ;~ 6~
electrogram from specific areas of the heart and more specifically, a predeteL ine~ electrogram parameter at each such area which has been shown to be reliable for indicating ischemia in the human heart. The apparatus is arranged to store the electrogram data for retrieval by the physician periodically and upon request by the physician through a command made by an external transmitter. As a result, the physician is provided with an early warning monitoring system of the state of the circulation in the patient's coronary arteries. As will be seen hereinafter, if the ischemia exceeds a predetermined limit, the apparatus provides the patient with a detectable alert signal informing the patient that the patient should consult his or her physician.
81J~Y OF THE INV~ ON
The present invention therefore provides an apparatus for assisting in the diagnosis of myocardial ischemia of a human heart. The apparatus is fully implantable beneath the skin of a patient and includes at least one electrode being implantable beneath the skin of a patient and arranged for establishing electrical contact with the heart. The apparatus further includes sensing means implantable beneath the skin of a patient and being coupled to the at least one electrode for generating an electrogram representative of the activity of the heart at the at least one electrode and wherein the electrogram includes 5T seqments having voltage magnitudes. The apparatus further includes read means implantable beneath the skin of a patient for reading the voltage magnitudes of the electrogram ST segments, memory means implantable beneath the skin of a patient and coupled to the read means for storing the ~oltagc magnitudes of the electrogram ST segments and communication means implantable beneath the skin of a patient and coupled to the memory means for transmitting the magnitudes o~ the electrogram ST segments to a nonimplanted external receiver.
The apparatus may further include a microprocessor arranged to determine the difference between the sensed ST segment voltages and a base line voltage and to activate an alarm means when the absolute magnitude of one of the differenses exceeds a commanded limit. The microprocessor may further be arranged to cause an ST segment voltage to be stored in the memory means only when the absolute magnitude of its corresponding difference exceeds a commanded limit.
10The present invention further provides a method for providing data for use in diagnosing myocardial ischemia of a human heart. The method includes the steps :
of providing at least one electrode, implanting the at least one electrode beneath the skin of a patient, establi~h;~g electrical contact between the at least one electrode and the heart of the patient, providing sensing means implanted beneath the skin of the patient coupled to the at least one electrode and generating an electrogram representative of the activity of the heart at the at least one electrode, wherein the electrogram includes ST segments. The method further includes the steps of providing voltage read means implanted beneath the skin of th~ patient, reading the voltage magnitudes o~ the electrogram ST segments, providing memory means implanted beneath the skin of the patient coupled to the voltage read means, storing the voltage magnitudes of the electrogram ST segments in the memory means, providing communication means implanted beneath the skin of the patient coupled to the memory means, and transmitting the magnitudes of thP electrogram ST segments to a nonimplanted external receive.r.
The present invention still further provides a method of providing data for use in diagnosing myocardial ischemia of a human heart. The method includes the steps of providing a plurality of electrodes, implanting the electrodes beneath the skin of a patient, and establishing electrical contact between the electrodes and respective different regions of the heart of the ' :, , : '' .', :
2~ 61~) patient. The method ~urther includes the steps of providing sensing means implanted beneath the skin o~ the patient coupled to the electrodes, and generating an electrogram for each electrode representative of the activity of the heart at each of the electrodes with electrogram including ST segments. The method further includes th~ steps of pro~iding voltage read means implanted beneath the skin of the patiPnt, reading the voltage magnitudes of the ST segments of each of the electrogram~, providing memory means implanted beneath the skin of the patient coupled to the voltage read means, and storing the voltage magnitudes of the ST
segments of each electrogram in said memory means. The method also includes the steps of providing communication means implanted beneath the skin of the patient coupled to the memory means, and transmitting the magnitudes of the electrogram ST segments to a nonimplanted external receiver.
BRIEF DE~CRIP~ION OF DRAWINGS
The features of the present invention whlch are believed to be novel are set forth with particularity in the appended claims. The invention, together with further objects and advantages thereof, may best be understood by making re~erence to the following description taken in conjunction with the accompanying drawings, and the several figures of which like reference numerals identify identical elements, and wherein:
Figure 1 illustrates a representative electrogram of a healthy human heart;
Figure 2 illustrates a representative electrogram of a human heart su~fering from ischemia; and Figu-e 3 is a schematic block diagram of a fully implantable apparatus embodying the present invention for assisting in the diagnosis of myocardial ischemia of a human heart and which is shown in association with a human heart in need of monitoring for ischemia.
:
DEBCRIPTION OF ~HE PR~F~RRBD EMBODI~BNT
Re~rring now to Figure 1, it illustrates an electrogram 10 representative of the electrical activity of a healthy heart. As will be noted, the electrogram 10 includes a QRS complex 12 which is preceded by a base line 14 and which is followed by an ST segment 16. As will also be noted from the electrogram 10, the voltage magnitude (ST) of the ST segment 16 is approximately equal to the voltage magnitude (BL) of the base line section 14 in the healthy heart.
Referring now to Figure 2, it illustrate~ a representative electrogram 20 of a human heart suffering from ischemia. The electrogram 20 like the electrogram 10 includes a QRS complex 22 which is preceded by a base line 24 and which is followed by an ST segment 26. As can be noted from Figure 2, the magnitude (ST) of the ST
segment voltage is greater than the maynitude (BL) of the voltage of the base line 24. The difference between the voltage of the base line 24 and thP voltage of the ST
segment 26 is referred to in the art as the ST seyment voltage shift.
The ST segment voltage shift may be either in a positive or a negative direction depending upon the type of electrode used (bipolar or unipolar) and the position of the electrode relative to the ischemic tissue. As indicated in Figure 2, the voltage shift is in the positive direction which will normally result with unipolar electrodes. Hence, human hearts sufferinq from ischemia may have either a negative or positive shift detected in the ST segment voltage. As a result, the absolute magnitude or value of the difference between the base line voltage and the voltage of the ST segment is considered to be a reliable indic~t~~ of potential ischemia in the human heart and, for example, a predetermined limit difference or shift of approximately five millivolts may be considered to indicate a condition of ischemia in the human heart. As will be seen hereinafter, the ischemia monitor of the present . . ' ' ' '~ ~ , .. .... : ~ ~ ; ' . .
6~
invention reads th~ voltage magnitude of the ST segment following the QRS complex.
Referring now to Fi~ure 3, it illustrates an ischemia monitor 30 embodying the present invention shown in association with a schematically represented human heart 32 in need of monitoring for myocardial ischemia.
The heart 32 illustrated in Figure 3 is shown to generally include a right atria 34, a right ventricle 36, a left atria 38, and a left ventricle 40. The right ventricle 36 and left ventricle 4n are shown in cross section to reveal myocardium regions 42 and 44 which may possibly suffer from ischemia.
The apparatus 30 generally includes a plurality of electrodes 50, 52, and 54, a sensing means 56, a read means 58, a memory 60, and communication means 62. All of the components of the apparatus 30 are contained within a common inclosure indicated by the dashed lina 64 except for those portions of electrodes 50, 52, and 54 which exte~ vutside o~ the common inclosure 64.
The electrodes 50, 52, and 54, as illustrated in Figure 3, are epicardial electrodes and are thus arranged to be attached to the outer surface of the heart 32 in the region of the myocardium 42 and 44.
Preferably, if the location of the region of potential myocardial ischemia is known, it is preferred to place the electrodes 50, 52, and 54 over or near each myocardial infarction or ischemic region where restenosis is considered to be most likely to occur. Such re~ions would be, for example, where grafts were made during coronary artery bypass graft surgery, for example. The electrodes 50, 52, and 54 are unipolar electrodes having poles 66, 68, and 70 respectively. The poles 66, 68, and 70 are placed into electrical contact with the hea_t by either being placed directly on the heart or to tissue near the heart for picking up electrical activity such as electrical activations within the heart 32O "
The sensing m~ans 56 comprises a plurality of sense amplifiers 72, 74, 76, and 78 with sense amplifiers ' .
2~ 6~
72, 74, and 76 having inputs coupled to the electrodes 50, 52, and 54. Although three electrodes are illustrated in the figure, it is contemplated by the present invention that a fewer or greater number of electrodes may be utilized without departing from the present invention. As a result, an electrogram is generated ~or each of the electrodes with each electrogram independently representing the activity of the heart 32 at each respective electrode pole and hence at each respective region of the heart being monitored.
The read means 58 is preferably an analog to digital converter 80 which is coupled to the outputs of the sense amplifiers 72, 74, 76, and 78 one at a time by a multiplexer 82. The analog to digital converter 80 reads the electrocardiogram voltages relative to a reference voltage su5h as the voltage of enclosure 64 and converts the electrocardiogram voltages to multiple-bit words in parallel-bit format. ~he multiple-bit representations of the electrogram voltages are processed by a microprocessor 84.
As will be noted in Figure 3, the microprocessor 84 is coupled to a clock source 86 and to the multiplexer 82. The microprocessor is also coupled to the memory 60 by a multiple-bit address bus 88 and a bi-directional multiple-bit data bus 90. The address bus 88 permits the microprocessor 84 to address desired memory locations within the memory 60 for executing write or read operations. During a write operation, the microprocessor stores data in the memory 60 at the addresses defined by the multiple-bit addresses conveyed over bus 88 and conveys the data to the memory 60 over the multiple-bit bus 90. During a read operation, the microprocessor 84 obtains data from the memory 60 from the s orage locations identified by the multiple-bit addresses provided over bus 88 and receives the data from the memory 60 over the bi-directional bus 90.
The microprocessor 84 controls the reading of the electrogram voltages and the storing of data, such as _1~ d~
_ 9 the magnitudes of the ST segment voltages, in the memory 60. By being coupled to the clock 86 and to the multiplexer 82, the microprocessor 84 is able to select which one of the inputs of the multiplexer is to be c~upled to the input of the analog to digital converter 80 and to synchronously store the data in the memory 60.
The microprocessor samples the ~lectrogram voltages provided by the sense amplifiers 72, 74, and 76 as digitized by the analog to digital converter 80 at a rapid rate and detects when the slope of the electrogram i5 either a rapid positive or ne~ative slope which may be saen in the elestrograms of Figures 1 and 2. Following the detected rapid positive or negative slope in the electrogram, the microprocessor then looks to obtain the ST segment voltage ~rom the analog to digital converter 80 from each of the sense amplifiers 72, 74, and 76.
Preferably, the microprocessor obtains the ST segment voltage a predetermined time after the QRS complex 22 is detected by the detection of the rapid positive or negative slope in the electrogram. Such a predetermined time may be, for example, 80 ms.
As an alternative to the configuration illustrated in Yigure 3, the inputs of multiplexer 82 may be coupled directly to the electrodes SO, 52, and 54 with the output of the multiplexer then being coupled to a single sense amplifier. This would have the benefit of lower power consumption and assuring the same amplifying gain being applied to each electrogram. However, this would also result in slower voltage sampling due to voltage settling times.
The communication means 62 includes a receiver/transmitter 63 and a transmitting coil 65. Such communication means are well ~nown in the art and may be utilized for receiving commands from external to the implantable enclosure 64 and f or transmitting data to a receiver external to the implanted enclosure 64. One such communication system is disclosed, for example, in U.S. Patent No. 4,586,508. The rece.iver/transmitter is 2~ 6~
coupled to the microprocessor 84 for conveying co~m~n~
to the microprocessor and for receiving data from the microprocessor which the microprocessor acquires from the memory 60.
The microprocessor in receiving commands from external to the implanted enclosure 64 may be provide~
with a predetermined voltage level of the patient, such as ~he base line voltage, by the physician. When the microprocessor identifies the ST segment voltage, it may then determine the difference between the ST segment voltage and the base line voltage. If the absolute magnitude of the resulting difference is greater than a predetermined limit which may also be provided from external to the enclosure 64 by the physician, the microprocessor then may cause either the ST se~ment voltage or the determined diffPrence (ST segment shift) to be entered into the memory 60. Since not all measured data is entered, in this manner, memory space within memory 60 may be conserved for only ST segment readings which are considered important to the physician. Also, for the ST segment voltages or voltage differences entered into the memory 60, the microprocessor may time stamp each entry so that upon being read out by the physician, the physician will know when the significant events occurred.
The microprocessor may also be programmed to determine the base line voltage on its own. This may be accomplished by storing the base line voltages and then, after the detection of a QRS complex, accessing the memory for the base line voltage measured a second predetermined time before the QRS complex. Such a second predetermined time may be 80 ms. Once having determined the base line voltage and after having the corresponding ST segment voltage, the microprocessor can then calculate the absolute value of the ST segment voltage shift. As a further alternative, capacitive coupling may be utilized to force the base line voltage seen by the microprocessor to be zero volts.
2~
For obtaining data from the implanted monitor 30, the physician requests the data from external to the enclosure 64. The c~_ ~nd is detected by the receiver/transmitter 63 and then conveyed to the microprocessor. In response to receiving the external cu ~nfl, the microprocessor 8~ addresses the memory 60 to obtain the data stored in the memory 60. The microprocessor then conveys the data to the receiver/transmitter 63 which then transmits the data to an external receiver for readout by the physician.
It will al50 be noted that in Figure 3, the apparatus 30 includes an alert means 100 which is coupled to the microprocessor 84. The alert means 100 may be an audio transducer 102 or may be a mechanical transducer to provide a detectable alarm which may be detected by the patient. When at least one ST segment shift determined by the microprocessor 84 is above a preset limit, which may be programmed into the microprocessor 84 from external to the apparatus 30 by the physician, the microprocessor then may be arranged to cause the alert means 100 to provide an alarm to the patient to inform the patient that the patient should consult his or her physician. Alternatively, if less sensitivity is desired, the microprocessor 84 may be programmed to activate the alarm only a~ter a precletermined plurality of ST segment shifts, as for example, five ST segment shifts, have exceeded the preset limit. As a result, the apparatus 30 is capable of alerting the patient to a potential myocardial infarction episode before one occurs.
While a particular embodiment of present invention has been shown and described, modifications may be made, and it is therefore intended to cover in the appended claims all such changes and modifications which fall within th~ true spirit and scopP of the invention.
.
:
.
.
electrogram from specific areas of the heart and more specifically, a predeteL ine~ electrogram parameter at each such area which has been shown to be reliable for indicating ischemia in the human heart. The apparatus is arranged to store the electrogram data for retrieval by the physician periodically and upon request by the physician through a command made by an external transmitter. As a result, the physician is provided with an early warning monitoring system of the state of the circulation in the patient's coronary arteries. As will be seen hereinafter, if the ischemia exceeds a predetermined limit, the apparatus provides the patient with a detectable alert signal informing the patient that the patient should consult his or her physician.
81J~Y OF THE INV~ ON
The present invention therefore provides an apparatus for assisting in the diagnosis of myocardial ischemia of a human heart. The apparatus is fully implantable beneath the skin of a patient and includes at least one electrode being implantable beneath the skin of a patient and arranged for establishing electrical contact with the heart. The apparatus further includes sensing means implantable beneath the skin of a patient and being coupled to the at least one electrode for generating an electrogram representative of the activity of the heart at the at least one electrode and wherein the electrogram includes 5T seqments having voltage magnitudes. The apparatus further includes read means implantable beneath the skin of a patient for reading the voltage magnitudes of the electrogram ST segments, memory means implantable beneath the skin of a patient and coupled to the read means for storing the ~oltagc magnitudes of the electrogram ST segments and communication means implantable beneath the skin of a patient and coupled to the memory means for transmitting the magnitudes o~ the electrogram ST segments to a nonimplanted external receiver.
The apparatus may further include a microprocessor arranged to determine the difference between the sensed ST segment voltages and a base line voltage and to activate an alarm means when the absolute magnitude of one of the differenses exceeds a commanded limit. The microprocessor may further be arranged to cause an ST segment voltage to be stored in the memory means only when the absolute magnitude of its corresponding difference exceeds a commanded limit.
10The present invention further provides a method for providing data for use in diagnosing myocardial ischemia of a human heart. The method includes the steps :
of providing at least one electrode, implanting the at least one electrode beneath the skin of a patient, establi~h;~g electrical contact between the at least one electrode and the heart of the patient, providing sensing means implanted beneath the skin of the patient coupled to the at least one electrode and generating an electrogram representative of the activity of the heart at the at least one electrode, wherein the electrogram includes ST segments. The method further includes the steps of providing voltage read means implanted beneath the skin of th~ patient, reading the voltage magnitudes o~ the electrogram ST segments, providing memory means implanted beneath the skin of the patient coupled to the voltage read means, storing the voltage magnitudes of the electrogram ST segments in the memory means, providing communication means implanted beneath the skin of the patient coupled to the memory means, and transmitting the magnitudes of thP electrogram ST segments to a nonimplanted external receive.r.
The present invention still further provides a method of providing data for use in diagnosing myocardial ischemia of a human heart. The method includes the steps of providing a plurality of electrodes, implanting the electrodes beneath the skin of a patient, and establishing electrical contact between the electrodes and respective different regions of the heart of the ' :, , : '' .', :
2~ 61~) patient. The method ~urther includes the steps of providing sensing means implanted beneath the skin o~ the patient coupled to the electrodes, and generating an electrogram for each electrode representative of the activity of the heart at each of the electrodes with electrogram including ST segments. The method further includes th~ steps of pro~iding voltage read means implanted beneath the skin of the patiPnt, reading the voltage magnitudes of the ST segments of each of the electrogram~, providing memory means implanted beneath the skin of the patient coupled to the voltage read means, and storing the voltage magnitudes of the ST
segments of each electrogram in said memory means. The method also includes the steps of providing communication means implanted beneath the skin of the patient coupled to the memory means, and transmitting the magnitudes of the electrogram ST segments to a nonimplanted external receiver.
BRIEF DE~CRIP~ION OF DRAWINGS
The features of the present invention whlch are believed to be novel are set forth with particularity in the appended claims. The invention, together with further objects and advantages thereof, may best be understood by making re~erence to the following description taken in conjunction with the accompanying drawings, and the several figures of which like reference numerals identify identical elements, and wherein:
Figure 1 illustrates a representative electrogram of a healthy human heart;
Figure 2 illustrates a representative electrogram of a human heart su~fering from ischemia; and Figu-e 3 is a schematic block diagram of a fully implantable apparatus embodying the present invention for assisting in the diagnosis of myocardial ischemia of a human heart and which is shown in association with a human heart in need of monitoring for ischemia.
:
DEBCRIPTION OF ~HE PR~F~RRBD EMBODI~BNT
Re~rring now to Figure 1, it illustrates an electrogram 10 representative of the electrical activity of a healthy heart. As will be noted, the electrogram 10 includes a QRS complex 12 which is preceded by a base line 14 and which is followed by an ST segment 16. As will also be noted from the electrogram 10, the voltage magnitude (ST) of the ST segment 16 is approximately equal to the voltage magnitude (BL) of the base line section 14 in the healthy heart.
Referring now to Figure 2, it illustrate~ a representative electrogram 20 of a human heart suffering from ischemia. The electrogram 20 like the electrogram 10 includes a QRS complex 22 which is preceded by a base line 24 and which is followed by an ST segment 26. As can be noted from Figure 2, the magnitude (ST) of the ST
segment voltage is greater than the maynitude (BL) of the voltage of the base line 24. The difference between the voltage of the base line 24 and thP voltage of the ST
segment 26 is referred to in the art as the ST seyment voltage shift.
The ST segment voltage shift may be either in a positive or a negative direction depending upon the type of electrode used (bipolar or unipolar) and the position of the electrode relative to the ischemic tissue. As indicated in Figure 2, the voltage shift is in the positive direction which will normally result with unipolar electrodes. Hence, human hearts sufferinq from ischemia may have either a negative or positive shift detected in the ST segment voltage. As a result, the absolute magnitude or value of the difference between the base line voltage and the voltage of the ST segment is considered to be a reliable indic~t~~ of potential ischemia in the human heart and, for example, a predetermined limit difference or shift of approximately five millivolts may be considered to indicate a condition of ischemia in the human heart. As will be seen hereinafter, the ischemia monitor of the present . . ' ' ' '~ ~ , .. .... : ~ ~ ; ' . .
6~
invention reads th~ voltage magnitude of the ST segment following the QRS complex.
Referring now to Fi~ure 3, it illustrates an ischemia monitor 30 embodying the present invention shown in association with a schematically represented human heart 32 in need of monitoring for myocardial ischemia.
The heart 32 illustrated in Figure 3 is shown to generally include a right atria 34, a right ventricle 36, a left atria 38, and a left ventricle 40. The right ventricle 36 and left ventricle 4n are shown in cross section to reveal myocardium regions 42 and 44 which may possibly suffer from ischemia.
The apparatus 30 generally includes a plurality of electrodes 50, 52, and 54, a sensing means 56, a read means 58, a memory 60, and communication means 62. All of the components of the apparatus 30 are contained within a common inclosure indicated by the dashed lina 64 except for those portions of electrodes 50, 52, and 54 which exte~ vutside o~ the common inclosure 64.
The electrodes 50, 52, and 54, as illustrated in Figure 3, are epicardial electrodes and are thus arranged to be attached to the outer surface of the heart 32 in the region of the myocardium 42 and 44.
Preferably, if the location of the region of potential myocardial ischemia is known, it is preferred to place the electrodes 50, 52, and 54 over or near each myocardial infarction or ischemic region where restenosis is considered to be most likely to occur. Such re~ions would be, for example, where grafts were made during coronary artery bypass graft surgery, for example. The electrodes 50, 52, and 54 are unipolar electrodes having poles 66, 68, and 70 respectively. The poles 66, 68, and 70 are placed into electrical contact with the hea_t by either being placed directly on the heart or to tissue near the heart for picking up electrical activity such as electrical activations within the heart 32O "
The sensing m~ans 56 comprises a plurality of sense amplifiers 72, 74, 76, and 78 with sense amplifiers ' .
2~ 6~
72, 74, and 76 having inputs coupled to the electrodes 50, 52, and 54. Although three electrodes are illustrated in the figure, it is contemplated by the present invention that a fewer or greater number of electrodes may be utilized without departing from the present invention. As a result, an electrogram is generated ~or each of the electrodes with each electrogram independently representing the activity of the heart 32 at each respective electrode pole and hence at each respective region of the heart being monitored.
The read means 58 is preferably an analog to digital converter 80 which is coupled to the outputs of the sense amplifiers 72, 74, 76, and 78 one at a time by a multiplexer 82. The analog to digital converter 80 reads the electrocardiogram voltages relative to a reference voltage su5h as the voltage of enclosure 64 and converts the electrocardiogram voltages to multiple-bit words in parallel-bit format. ~he multiple-bit representations of the electrogram voltages are processed by a microprocessor 84.
As will be noted in Figure 3, the microprocessor 84 is coupled to a clock source 86 and to the multiplexer 82. The microprocessor is also coupled to the memory 60 by a multiple-bit address bus 88 and a bi-directional multiple-bit data bus 90. The address bus 88 permits the microprocessor 84 to address desired memory locations within the memory 60 for executing write or read operations. During a write operation, the microprocessor stores data in the memory 60 at the addresses defined by the multiple-bit addresses conveyed over bus 88 and conveys the data to the memory 60 over the multiple-bit bus 90. During a read operation, the microprocessor 84 obtains data from the memory 60 from the s orage locations identified by the multiple-bit addresses provided over bus 88 and receives the data from the memory 60 over the bi-directional bus 90.
The microprocessor 84 controls the reading of the electrogram voltages and the storing of data, such as _1~ d~
_ 9 the magnitudes of the ST segment voltages, in the memory 60. By being coupled to the clock 86 and to the multiplexer 82, the microprocessor 84 is able to select which one of the inputs of the multiplexer is to be c~upled to the input of the analog to digital converter 80 and to synchronously store the data in the memory 60.
The microprocessor samples the ~lectrogram voltages provided by the sense amplifiers 72, 74, and 76 as digitized by the analog to digital converter 80 at a rapid rate and detects when the slope of the electrogram i5 either a rapid positive or ne~ative slope which may be saen in the elestrograms of Figures 1 and 2. Following the detected rapid positive or negative slope in the electrogram, the microprocessor then looks to obtain the ST segment voltage ~rom the analog to digital converter 80 from each of the sense amplifiers 72, 74, and 76.
Preferably, the microprocessor obtains the ST segment voltage a predetermined time after the QRS complex 22 is detected by the detection of the rapid positive or negative slope in the electrogram. Such a predetermined time may be, for example, 80 ms.
As an alternative to the configuration illustrated in Yigure 3, the inputs of multiplexer 82 may be coupled directly to the electrodes SO, 52, and 54 with the output of the multiplexer then being coupled to a single sense amplifier. This would have the benefit of lower power consumption and assuring the same amplifying gain being applied to each electrogram. However, this would also result in slower voltage sampling due to voltage settling times.
The communication means 62 includes a receiver/transmitter 63 and a transmitting coil 65. Such communication means are well ~nown in the art and may be utilized for receiving commands from external to the implantable enclosure 64 and f or transmitting data to a receiver external to the implanted enclosure 64. One such communication system is disclosed, for example, in U.S. Patent No. 4,586,508. The rece.iver/transmitter is 2~ 6~
coupled to the microprocessor 84 for conveying co~m~n~
to the microprocessor and for receiving data from the microprocessor which the microprocessor acquires from the memory 60.
The microprocessor in receiving commands from external to the implanted enclosure 64 may be provide~
with a predetermined voltage level of the patient, such as ~he base line voltage, by the physician. When the microprocessor identifies the ST segment voltage, it may then determine the difference between the ST segment voltage and the base line voltage. If the absolute magnitude of the resulting difference is greater than a predetermined limit which may also be provided from external to the enclosure 64 by the physician, the microprocessor then may cause either the ST se~ment voltage or the determined diffPrence (ST segment shift) to be entered into the memory 60. Since not all measured data is entered, in this manner, memory space within memory 60 may be conserved for only ST segment readings which are considered important to the physician. Also, for the ST segment voltages or voltage differences entered into the memory 60, the microprocessor may time stamp each entry so that upon being read out by the physician, the physician will know when the significant events occurred.
The microprocessor may also be programmed to determine the base line voltage on its own. This may be accomplished by storing the base line voltages and then, after the detection of a QRS complex, accessing the memory for the base line voltage measured a second predetermined time before the QRS complex. Such a second predetermined time may be 80 ms. Once having determined the base line voltage and after having the corresponding ST segment voltage, the microprocessor can then calculate the absolute value of the ST segment voltage shift. As a further alternative, capacitive coupling may be utilized to force the base line voltage seen by the microprocessor to be zero volts.
2~
For obtaining data from the implanted monitor 30, the physician requests the data from external to the enclosure 64. The c~_ ~nd is detected by the receiver/transmitter 63 and then conveyed to the microprocessor. In response to receiving the external cu ~nfl, the microprocessor 8~ addresses the memory 60 to obtain the data stored in the memory 60. The microprocessor then conveys the data to the receiver/transmitter 63 which then transmits the data to an external receiver for readout by the physician.
It will al50 be noted that in Figure 3, the apparatus 30 includes an alert means 100 which is coupled to the microprocessor 84. The alert means 100 may be an audio transducer 102 or may be a mechanical transducer to provide a detectable alarm which may be detected by the patient. When at least one ST segment shift determined by the microprocessor 84 is above a preset limit, which may be programmed into the microprocessor 84 from external to the apparatus 30 by the physician, the microprocessor then may be arranged to cause the alert means 100 to provide an alarm to the patient to inform the patient that the patient should consult his or her physician. Alternatively, if less sensitivity is desired, the microprocessor 84 may be programmed to activate the alarm only a~ter a precletermined plurality of ST segment shifts, as for example, five ST segment shifts, have exceeded the preset limit. As a result, the apparatus 30 is capable of alerting the patient to a potential myocardial infarction episode before one occurs.
While a particular embodiment of present invention has been shown and described, modifications may be made, and it is therefore intended to cover in the appended claims all such changes and modifications which fall within th~ true spirit and scopP of the invention.
.
:
.
.
Claims (31)
1. An apparatus for assisting in the diagnosis of myocardial ischemia of a human heart, said apparatus being fully implantable beneath the skin of a patient and comprising:
at least one electrode, said electrode being implantable beneath the skin of a patient and arranged for establishing electrical contact with the heart;
sensing means implantable beneath the skin of a patient, said sensing means being coupled to said at least one electrode for generating an electrogram representative of the activity of the heart at said at least one electrode, said electrogram including ST
segments having voltage magnitudes;
read means implantable beneath the skin of a patient for reading the voltage magnitudes of said electrogram ST segments;
memory means implantable beneath the skin of a patient and coupled to said read means for storing the voltage magnitudes of said electrogram ST segments; and communication means implantable beneath the skin of a patient and coupled to said memory means for transmitting said magnitudes of said electrogram ST
segments to a nonimplanted external receiver.
at least one electrode, said electrode being implantable beneath the skin of a patient and arranged for establishing electrical contact with the heart;
sensing means implantable beneath the skin of a patient, said sensing means being coupled to said at least one electrode for generating an electrogram representative of the activity of the heart at said at least one electrode, said electrogram including ST
segments having voltage magnitudes;
read means implantable beneath the skin of a patient for reading the voltage magnitudes of said electrogram ST segments;
memory means implantable beneath the skin of a patient and coupled to said read means for storing the voltage magnitudes of said electrogram ST segments; and communication means implantable beneath the skin of a patient and coupled to said memory means for transmitting said magnitudes of said electrogram ST
segments to a nonimplanted external receiver.
2. An apparatus as defined in claim 1 including a plurality of said electrodes and wherein said sensing means is arranged to generate an electrogram for each said electrode.
3. An apparatus as defined in claim 2 wherein said electrodes are arranged to be attached to the human heart.
4. An apparatus as defined in claim 1 wherein said read means comprises an analog to digital converter.
5. An apparatus as defined in claim 2 wherein said sensing means comprises a plurality of sense amplifiers, each said sense amplifier being coupled to a respective one of said electrodes.
6. An apparatus as defined in claim 5 further including a multiplexer having a plurality of inputs coupled to said sense amplifiers and an output coupled to said read means for coupling each of said sense amplifiers to said read means one at a time.
7. An apparatus as defined in claim 6 wherein said read means comprises an analog to digital converter.
8. An apparatus as defined in claim 1 wherein said sensing means, said read means, said memory means, and said communication means are enclosed within a common enclosure.
9. An apparatus as defined in claim 2 wherein said electrodes are unipolar electrodes.
10. An apparatus as defined in claim 1 further including a microprocessor coupled between said read means and said memory means for controlling the reading of said electrogram ST segment voltages and the storing of said ST segment voltage magnitudes in said memory means.
11. An apparatus as defined in claim 10 wherein said microprocessor is coupled between said memory means and said communication means.
12. An apparatus as defined in claim 11 wherein said communication means is arranged for receiving commands from an external source.
13. An apparatus as defined in claim 12 wherein said microprocessor is arranged to determine the difference between said sensed ST segment voltages and a base line voltage and to activate an alert means when the absolute magnitude of at least one of said differences exceeds a commanded limit.
14. An apparatus as defined in claim 12 wherein said microprocessor is arranged to determine the difference between said sensed ST segment voltage and said base line voltage and to cause an ST segment voltage magnitude to be stored in said memory means only when the absolute magnitude of its corresponding difference exceeds a commanded limit.
15. An apparatus as defined in claim 14 wherein said microprocessor is further arranged to provide a time stamp for each ST segment voltage magnitude entered into said memory means.
16. A method of providing data for use in diagnosing myocardial ischemia of a human heart, said method including the steps of:
providing at least one electrode;
implanting said electrode beneath the skin of a patient;
establishing electrical contact between said electrode and the heart of the patient;
providing sensing means implanted beneath the skin of the patient coupled to said electrode;
generating an electrogram for said electrode representative of the activity of the heart at said electrode, said electrogram including ST segments;
providing voltage read means implanted beneath the skin of the patient;
reading the voltage magnitudes of said electrogram ST segments;
providing memory means implanted beneath the skin of the patient coupled to said voltage read means;
storing the voltage magnitudes of said electrogram ST segments in said memory means;
providing communication means implanted beneath the skin of the patient coupled to said memory means; and transmitting said magnitudes of said electrogram ST segments to a non implanted external receiver.
providing at least one electrode;
implanting said electrode beneath the skin of a patient;
establishing electrical contact between said electrode and the heart of the patient;
providing sensing means implanted beneath the skin of the patient coupled to said electrode;
generating an electrogram for said electrode representative of the activity of the heart at said electrode, said electrogram including ST segments;
providing voltage read means implanted beneath the skin of the patient;
reading the voltage magnitudes of said electrogram ST segments;
providing memory means implanted beneath the skin of the patient coupled to said voltage read means;
storing the voltage magnitudes of said electrogram ST segments in said memory means;
providing communication means implanted beneath the skin of the patient coupled to said memory means; and transmitting said magnitudes of said electrogram ST segments to a non implanted external receiver.
17. A method as defined in claim 16 wherein said electrode is an epicardial electrode.
18. A method as defined in claim 16 wherein said sensing means is formed of at least one sense amplifier, said at least one sense amplifier being coupled to said at least one electrode.
19. A method as defined in claim 18 further including the step of converting said ST segment voltages from analog form to digital form.
20. A method as defined in claim 19 further including the step of synchronizing the reading of said electrogram ST segment voltages and the storing of said ST segment voltage magnitudes in said memory means.
21. A method as defined in claim 16 including the further steps of determining the difference between said sensed ST segment voltages and a base line voltage and providing an alarm when the absolute magnitude of at least one of said differences exceeds a predetermined limit.
22. A method as defined in claim 16 including the further steps of determining the difference between each sensed ST segment voltage and a base line voltage and storing a sensed ST segment voltage magnitude in said memory only when the absolute magnitude of its corresponding difference exceeds a predetermined limit.
23. A method as defined in claim 22 including the further step of time stamping each stored ST segment voltage entry.
24. A method of providing data for use in diagnosing myocardial ischemia of a human heart, said method including the steps of:
providing a plurality of electrodes;
implanting said electrodes beneath the skin of a patient;
establishing electrical contact between said electrodes and respective different regions of the heart of the patient;
providing sensing means implanted beneath the skin of the patient coupled to said electrodes;
generating an electrogram for each said electrode representative of the activity of the heart at each said electrode, each said electrogram including ST
segments;
providing voltage read means implanted beneath the skin of the patient;
reading the voltage magnitudes of said ST
segments of each of said electrograms;
providing memory means implanted beneath the skin of the patient coupled to said voltage read means;
storing the voltage magnitudes of said ST
segments of each said electrogram in said memory means;
providing communication means implanted beneath the skin of the patient coupled to said memory means; and transmitting said magnitudes of said electrogram ST segments to a nonimplanted external receiver.
providing a plurality of electrodes;
implanting said electrodes beneath the skin of a patient;
establishing electrical contact between said electrodes and respective different regions of the heart of the patient;
providing sensing means implanted beneath the skin of the patient coupled to said electrodes;
generating an electrogram for each said electrode representative of the activity of the heart at each said electrode, each said electrogram including ST
segments;
providing voltage read means implanted beneath the skin of the patient;
reading the voltage magnitudes of said ST
segments of each of said electrograms;
providing memory means implanted beneath the skin of the patient coupled to said voltage read means;
storing the voltage magnitudes of said ST
segments of each said electrogram in said memory means;
providing communication means implanted beneath the skin of the patient coupled to said memory means; and transmitting said magnitudes of said electrogram ST segments to a nonimplanted external receiver.
25. A method as defined in claim 24 wherein said electrodes are epicardial electrodes.
26. A method as defined in claim 24 wherein said sensing means is formed of a plurality of sense amplifiers, each said sense amplifier being coupled to a respective one of said electrodes.
27. A method as defined in claim 24 further including the step of converting said ST segment voltages from analog form to digital form.
28. A method as defined in claim 24 further including the step of synchronizing the reading of said electrogram ST segment voltages and the storing of said ST segment voltage magnitudes in said memory means.
29. A method as defined in claim 24 including the further steps of determining the difference between said sensed ST segment voltages and a base line voltage and providing an alarm when the absolute magnitude of at least one of said differences exceeds a predetermined limit.
30. A method as defined in claim 24 including the further steps of determining the difference between each sensed ST segment voltage and a base line voltage and storing a sensed ST segment voltage magnitude in said memory only when the absolute magnitude of its corresponding difference exceeds a predetermined limit.
31. A method as defined in claim 30 including the further step of time stamping each stored ST segment voltage entry.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/667,819 US5135004A (en) | 1991-03-12 | 1991-03-12 | Implantable myocardial ischemia monitor and related method |
US07/667,819 | 1991-03-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2080460A1 CA2080460A1 (en) | 1992-09-13 |
CA2080460C true CA2080460C (en) | 1997-09-09 |
Family
ID=24679780
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002080460A Expired - Fee Related CA2080460C (en) | 1991-03-12 | 1992-03-10 | Myocardial ischemia monitor and related method |
Country Status (11)
Country | Link |
---|---|
US (1) | US5135004A (en) |
EP (1) | EP0529055B1 (en) |
JP (1) | JP3237844B2 (en) |
AT (1) | ATE152897T1 (en) |
AU (1) | AU641891B2 (en) |
CA (1) | CA2080460C (en) |
DE (1) | DE69219698T2 (en) |
DK (1) | DK0529055T3 (en) |
ES (1) | ES2101841T3 (en) |
GR (1) | GR3023931T3 (en) |
WO (1) | WO1992016143A1 (en) |
Families Citing this family (263)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2106378A1 (en) * | 1991-04-05 | 1992-10-06 | Tom D. Bennett | Subcutaneous multi-electrode sensing system |
US5161539A (en) * | 1991-05-09 | 1992-11-10 | Physio-Control | Method and apparatus for performing mapping-type analysis including use of limited electrode sets |
US5313953A (en) * | 1992-01-14 | 1994-05-24 | Incontrol, Inc. | Implantable cardiac patient monitor |
GB2264176B (en) * | 1992-02-14 | 1995-12-20 | George John Dempsey | A non-invasive multi-electrocardiographic apparatus and method of assessing acute ischaemic damage |
US5330507A (en) * | 1992-04-24 | 1994-07-19 | Medtronic, Inc. | Implantable electrical vagal stimulation for prevention or interruption of life threatening arrhythmias |
US5782890A (en) * | 1992-07-01 | 1998-07-21 | Medtronic, Inc. | Method for heart transplant monitoring and analog telemetry calibration |
DE4310412C1 (en) * | 1993-03-31 | 1994-07-21 | Manfred Dr Zehender | Device for signal analysis of the electrical potential profile of the heart excitation |
US5464435A (en) * | 1994-02-03 | 1995-11-07 | Medtronic, Inc. | Parallel processors in implantable medical device |
AU1376895A (en) * | 1994-12-23 | 1996-07-19 | Diane P Green | A personal gps security system |
JP3742675B2 (en) * | 1995-06-28 | 2006-02-08 | 東菱薬品工業株式会社 | Prophylactic and therapeutic agents for ischemia-reperfusion injury |
SE9701122D0 (en) * | 1997-03-26 | 1997-03-26 | Pacesetter Ab | Medical implant |
AU5394099A (en) | 1998-08-07 | 2000-02-28 | Infinite Biomedical Technologies, Incorporated | Implantable myocardial ischemia detection, indication and action technology |
US6112116A (en) * | 1999-02-22 | 2000-08-29 | Cathco, Inc. | Implantable responsive system for sensing and treating acute myocardial infarction |
US6714811B1 (en) | 1999-03-05 | 2004-03-30 | Medtronic, Inc. | Method and apparatus for monitoring heart rate |
US6508771B1 (en) | 1999-03-05 | 2003-01-21 | Medtronic, Inc. | Method and apparatus for monitoring heart rate |
US6272379B1 (en) | 1999-03-17 | 2001-08-07 | Cathco, Inc. | Implantable electronic system with acute myocardial infarction detection and patient warning capabilities |
US6115628A (en) | 1999-03-29 | 2000-09-05 | Medtronic, Inc. | Method and apparatus for filtering electrocardiogram (ECG) signals to remove bad cycle information and for use of physiologic signals determined from said filtered ECG signals |
US6115630A (en) * | 1999-03-29 | 2000-09-05 | Medtronic, Inc. | Determination of orientation of electrocardiogram signal in implantable medical devices |
US6324421B1 (en) * | 1999-03-29 | 2001-11-27 | Medtronic, Inc. | Axis shift analysis of electrocardiogram signal parameters especially applicable for multivector analysis by implantable medical devices, and use of same |
US6128526A (en) * | 1999-03-29 | 2000-10-03 | Medtronic, Inc. | Method for ischemia detection and apparatus for using same |
US6108577A (en) * | 1999-04-26 | 2000-08-22 | Cardiac Pacemakers, Inc. | Method and apparatus for detecting changes in electrocardiogram signals |
US6339720B1 (en) | 1999-09-20 | 2002-01-15 | Fernando Anzellini | Early warning apparatus for acute Myocardial Infarction in the first six hours of pain |
US6379300B1 (en) | 1999-10-08 | 2002-04-30 | Medtronic, Inc. | Telemtry system for implantable medical devices |
US6317626B1 (en) | 1999-11-03 | 2001-11-13 | Medtronic, Inc. | Method and apparatus for monitoring heart rate |
US6438407B1 (en) | 2000-03-20 | 2002-08-20 | Medtronic, Inc. | Method and apparatus for monitoring physiologic parameters conjunction with a treatment |
US6514195B1 (en) * | 2000-04-28 | 2003-02-04 | Medtronic, Inc. | Ischemic heart disease detection |
EP1330287B1 (en) * | 2000-10-26 | 2009-07-29 | Medtronic, Inc. | Apparatus to minimize the effects of a cardiac insult |
JP4177102B2 (en) | 2000-10-26 | 2008-11-05 | メドトロニック・インコーポレーテッド | Device for improving cardiac function and efficiency |
US6689117B2 (en) | 2000-12-18 | 2004-02-10 | Cardiac Pacemakers, Inc. | Drug delivery system for implantable medical device |
US6840800B2 (en) * | 2001-10-10 | 2005-01-11 | Quixemble, Inc. | Deflecting securement anchor for electrical fixtures |
US20070191895A1 (en) * | 2001-04-20 | 2007-08-16 | Foreman Robert D | Activation of cardiac alpha receptors by spinal cord stimulation produces cardioprotection against ischemia, arrhythmias, and heart failure |
EP1395330A1 (en) * | 2001-04-20 | 2004-03-10 | The Board of Regents for the University of Oklahoma | Cardiac neuromodulation and methods of using same |
US6468263B1 (en) | 2001-05-21 | 2002-10-22 | Angel Medical Systems, Inc. | Implantable responsive system for sensing and treating acute myocardial infarction and for treating stroke |
JP2004533297A (en) | 2001-05-29 | 2004-11-04 | メドトロニック・インコーポレーテッド | Closed loop neuromodulation system for prevention and treatment of heart disease |
US20030149354A1 (en) * | 2001-08-23 | 2003-08-07 | Bakharev Alexander A. | Ischemia identification, quantification and partial localization MCG |
US6937899B2 (en) | 2001-08-30 | 2005-08-30 | Medtronic, Inc. | Ischemia detection |
US6882883B2 (en) * | 2001-08-31 | 2005-04-19 | Medtronic, Inc. | Implantable medical device (IMD) system configurable to subject a patient to a stress test and to detect myocardial ischemia within the patient |
US7340303B2 (en) * | 2001-09-25 | 2008-03-04 | Cardiac Pacemakers, Inc. | Evoked response sensing for ischemia detection |
US7181268B2 (en) * | 2001-12-03 | 2007-02-20 | Medtronic, Inc. | Ischemia detection |
US6973349B2 (en) | 2001-12-05 | 2005-12-06 | Cardiac Pacemakers, Inc. | Method and apparatus for minimizing post-infarct ventricular remodeling |
US6865420B1 (en) | 2002-01-14 | 2005-03-08 | Pacesetter, Inc. | Cardiac stimulation device for optimizing cardiac output with myocardial ischemia protection |
US6985771B2 (en) * | 2002-01-22 | 2006-01-10 | Angel Medical Systems, Inc. | Rapid response system for the detection and treatment of cardiac events |
US20030149423A1 (en) * | 2002-02-04 | 2003-08-07 | Fischell Robert E. | Methods for the detection and treatment of cardiac events |
US20070015981A1 (en) * | 2003-08-29 | 2007-01-18 | Benaron David A | Device and methods for the detection of locally-weighted tissue ischemia |
US6711426B2 (en) * | 2002-04-09 | 2004-03-23 | Spectros Corporation | Spectroscopy illuminator with improved delivery efficiency for high optical density and reduced thermal load |
US20080009689A1 (en) * | 2002-04-09 | 2008-01-10 | Benaron David A | Difference-weighted somatic spectroscopy |
US7657482B1 (en) * | 2002-07-15 | 2010-02-02 | Paymentech, L.P. | System and apparatus for transaction fraud processing |
US6609023B1 (en) * | 2002-09-20 | 2003-08-19 | Angel Medical Systems, Inc. | System for the detection of cardiac events |
US7991460B2 (en) | 2002-09-20 | 2011-08-02 | Angel Medical Systems, Inc. | Methods and apparatus for detecting cardiac events based on heart rate sensitive parameters |
US8630702B2 (en) * | 2002-09-20 | 2014-01-14 | Angel Medical Systems, Inc. | System for detection of different types of cardiac events |
US7558623B2 (en) * | 2002-09-20 | 2009-07-07 | Angel Medical Systems, Inc. | Means and method for the detection of cardiac events |
US7801596B2 (en) * | 2002-09-20 | 2010-09-21 | Angel Medical Systems, Inc. | Physician's programmer for implantable devices having cardiac diagnostic and patient alerting capabilities |
US20080139954A1 (en) * | 2002-09-20 | 2008-06-12 | Mary Carol Day | System for at least two types of patient alerting associated with cardiac events |
US7415307B2 (en) * | 2002-10-31 | 2008-08-19 | Medtronic, Inc. | Ischemia detection based on cardiac conduction time |
US7627373B2 (en) | 2002-11-30 | 2009-12-01 | Cardiac Pacemakers, Inc. | Method and apparatus for cell and electrical therapy of living tissue |
EP1578262A4 (en) | 2002-12-31 | 2007-12-05 | Therasense Inc | Continuous glucose monitoring system and methods of use |
US7587287B2 (en) * | 2003-04-04 | 2009-09-08 | Abbott Diabetes Care Inc. | Method and system for transferring analyte test data |
US8066639B2 (en) | 2003-06-10 | 2011-11-29 | Abbott Diabetes Care Inc. | Glucose measuring device for use in personal area network |
US7274959B1 (en) | 2003-06-24 | 2007-09-25 | Pacesetter, Inc. | System and method for detecting cardiac ischemia using an implantable medical device |
US7225015B1 (en) | 2003-06-24 | 2007-05-29 | Pacesetter, Inc. | System and method for detecting cardiac ischemia based on T-waves using an implantable medical device |
US7218960B1 (en) | 2003-06-24 | 2007-05-15 | Pacesetter, Inc. | System and method for detecting cardiac ischemia based on T-waves using an implantable medical device |
US20190357827A1 (en) | 2003-08-01 | 2019-11-28 | Dexcom, Inc. | Analyte sensor |
US7320675B2 (en) | 2003-08-21 | 2008-01-22 | Cardiac Pacemakers, Inc. | Method and apparatus for modulating cellular metabolism during post-ischemia or heart failure |
US20050043639A1 (en) * | 2003-08-22 | 2005-02-24 | Fischell Robert E. | Method for decreasing mortality of hemodialysis patients |
US20050113886A1 (en) * | 2003-11-24 | 2005-05-26 | Fischell David R. | Implantable medical system with long range telemetry |
US7512438B2 (en) | 2003-11-26 | 2009-03-31 | Angel Medical Systems, Inc. | Implantable system for monitoring the condition of the heart |
US8244338B2 (en) | 2003-11-26 | 2012-08-14 | Angel Medical Systems, Inc. | Cardiac event detection over varying time scale |
US7215997B2 (en) * | 2003-12-22 | 2007-05-08 | Cardiac Pacemakers, Inc. | Dynamic device therapy control for treating post myocardial infarction patients |
US7668594B2 (en) | 2005-08-19 | 2010-02-23 | Cardiac Pacemakers, Inc. | Method and apparatus for delivering chronic and post-ischemia cardiac therapies |
DE102004005179B4 (en) * | 2004-02-02 | 2006-07-13 | Wobben, Aloys, Dipl.-Ing. | Wind turbine |
CA2556331A1 (en) | 2004-02-17 | 2005-09-29 | Therasense, Inc. | Method and system for providing data communication in continuous glucose monitoring and management system |
US7181269B1 (en) | 2004-04-12 | 2007-02-20 | Pacesetter, Inc. | Implantable device that diagnoses ischemia and myocardial infarction and method |
US7860559B2 (en) | 2004-05-26 | 2010-12-28 | Angel Medical Systems, Inc. | Means and method for the detection of cardiac events |
US20050277841A1 (en) * | 2004-06-10 | 2005-12-15 | Adnan Shennib | Disposable fetal monitor patch |
US20060030781A1 (en) * | 2004-08-05 | 2006-02-09 | Adnan Shennib | Emergency heart sensor patch |
US20060030782A1 (en) * | 2004-08-05 | 2006-02-09 | Adnan Shennib | Heart disease detection patch |
US7828711B2 (en) * | 2004-08-16 | 2010-11-09 | Cardiac Pacemakers, Inc. | Method and apparatus for modulating cellular growth and regeneration using ventricular assist device |
US8060219B2 (en) | 2004-12-20 | 2011-11-15 | Cardiac Pacemakers, Inc. | Epicardial patch including isolated extracellular matrix with pacing electrodes |
US7981065B2 (en) | 2004-12-20 | 2011-07-19 | Cardiac Pacemakers, Inc. | Lead electrode incorporating extracellular matrix |
US9636450B2 (en) | 2007-02-19 | 2017-05-02 | Udo Hoss | Pump system modular components for delivering medication and analyte sensing at seperate insertion sites |
US7697967B2 (en) | 2005-12-28 | 2010-04-13 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor insertion |
US7295874B2 (en) * | 2005-01-06 | 2007-11-13 | Cardiac Pacemakers, Inc. | Intermittent stress augmentation pacing for cardioprotective effect |
US7756572B1 (en) | 2005-01-25 | 2010-07-13 | Pacesetter, Inc. | System and method for efficiently distinguishing among cardiac ischemia, hypoglycemia and hyperglycemia using an implantable medical device and an external system |
US7297114B2 (en) * | 2005-01-25 | 2007-11-20 | Pacesetter, Inc. | System and method for distinguishing among cardiac ischemia, hypoglycemia and hyperglycemia using an implantable medical device |
US7590443B2 (en) * | 2005-04-27 | 2009-09-15 | Pacesetter, Inc | System and method for detecting hypoglycemia based on a paced depolarization integral using an implantable medical device |
US7366568B2 (en) | 2005-05-06 | 2008-04-29 | Cardiac Pacemakers, Inc. | Controlled delivery of intermittent stress augmentation pacing for cardioprotective effect |
US7894896B2 (en) * | 2005-05-13 | 2011-02-22 | Cardiac Pacemakers, Inc. | Method and apparatus for initiating and delivering cardiac protection pacing |
US20060259088A1 (en) * | 2005-05-13 | 2006-11-16 | Pastore Joseph M | Method and apparatus for delivering pacing pulses using a coronary stent |
US7917210B2 (en) * | 2005-05-13 | 2011-03-29 | Cardiac Pacemakers, Inc. | Method and apparatus for cardiac protection pacing |
US8688189B2 (en) * | 2005-05-17 | 2014-04-01 | Adnan Shennib | Programmable ECG sensor patch |
US7922669B2 (en) | 2005-06-08 | 2011-04-12 | Cardiac Pacemakers, Inc. | Ischemia detection using a heart sound sensor |
US20070016089A1 (en) * | 2005-07-15 | 2007-01-18 | Fischell David R | Implantable device for vital signs monitoring |
US7813778B2 (en) * | 2005-07-29 | 2010-10-12 | Spectros Corporation | Implantable tissue ischemia sensor |
US20070036770A1 (en) * | 2005-08-12 | 2007-02-15 | Wagner Darrell O | Biologic device for regulation of gene expression and method therefor |
US8838215B2 (en) * | 2006-03-01 | 2014-09-16 | Angel Medical Systems, Inc. | Systems and methods of medical monitoring according to patient state |
CN101365374B (en) | 2005-08-31 | 2011-11-16 | 弗吉尼亚大学专利基金委员会 | Improving accuracy of continuous glucose sensors |
US8880138B2 (en) | 2005-09-30 | 2014-11-04 | Abbott Diabetes Care Inc. | Device for channeling fluid and methods of use |
US9168383B2 (en) | 2005-10-14 | 2015-10-27 | Pacesetter, Inc. | Leadless cardiac pacemaker with conducted communication |
US8457742B2 (en) | 2005-10-14 | 2013-06-04 | Nanostim, Inc. | Leadless cardiac pacemaker system for usage in combination with an implantable cardioverter-defibrillator |
US7766829B2 (en) | 2005-11-04 | 2010-08-03 | Abbott Diabetes Care Inc. | Method and system for providing basal profile modification in analyte monitoring and management systems |
US7885710B2 (en) | 2005-12-23 | 2011-02-08 | Cardiac Pacemakers, Inc. | Method and apparatus for tissue protection against ischemia using remote conditioning |
US11298058B2 (en) | 2005-12-28 | 2022-04-12 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor insertion |
US7736310B2 (en) | 2006-01-30 | 2010-06-15 | Abbott Diabetes Care Inc. | On-body medical device securement |
US20070191728A1 (en) * | 2006-02-10 | 2007-08-16 | Adnan Shennib | Intrapartum monitor patch |
US20070255184A1 (en) * | 2006-02-10 | 2007-11-01 | Adnan Shennib | Disposable labor detection patch |
US8112149B2 (en) * | 2006-02-27 | 2012-02-07 | Monitoring Information Technologies, Inc. | System and method for heart and activity monitoring |
US7826879B2 (en) | 2006-02-28 | 2010-11-02 | Abbott Diabetes Care Inc. | Analyte sensors and methods of use |
US7981034B2 (en) | 2006-02-28 | 2011-07-19 | Abbott Diabetes Care Inc. | Smart messages and alerts for an infusion delivery and management system |
US8781566B2 (en) * | 2006-03-01 | 2014-07-15 | Angel Medical Systems, Inc. | System and methods for sliding-scale cardiac event detection |
US8002701B2 (en) | 2006-03-10 | 2011-08-23 | Angel Medical Systems, Inc. | Medical alarm and communication system and methods |
US7620438B2 (en) | 2006-03-31 | 2009-11-17 | Abbott Diabetes Care Inc. | Method and system for powering an electronic device |
US8140312B2 (en) | 2007-05-14 | 2012-03-20 | Abbott Diabetes Care Inc. | Method and system for determining analyte levels |
US7618369B2 (en) | 2006-10-02 | 2009-11-17 | Abbott Diabetes Care Inc. | Method and system for dynamically updating calibration parameters for an analyte sensor |
US8346335B2 (en) | 2008-03-28 | 2013-01-01 | Abbott Diabetes Care Inc. | Analyte sensor calibration management |
US8219173B2 (en) | 2008-09-30 | 2012-07-10 | Abbott Diabetes Care Inc. | Optimizing analyte sensor calibration |
US9675290B2 (en) | 2012-10-30 | 2017-06-13 | Abbott Diabetes Care Inc. | Sensitivity calibration of in vivo sensors used to measure analyte concentration |
US8224415B2 (en) | 2009-01-29 | 2012-07-17 | Abbott Diabetes Care Inc. | Method and device for providing offset model based calibration for analyte sensor |
US9392969B2 (en) | 2008-08-31 | 2016-07-19 | Abbott Diabetes Care Inc. | Closed loop control and signal attenuation detection |
US8226891B2 (en) | 2006-03-31 | 2012-07-24 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods therefor |
US7630748B2 (en) | 2006-10-25 | 2009-12-08 | Abbott Diabetes Care Inc. | Method and system for providing analyte monitoring |
US8374668B1 (en) | 2007-10-23 | 2013-02-12 | Abbott Diabetes Care Inc. | Analyte sensor with lag compensation |
US9326709B2 (en) * | 2010-03-10 | 2016-05-03 | Abbott Diabetes Care Inc. | Systems, devices and methods for managing glucose levels |
US8473022B2 (en) | 2008-01-31 | 2013-06-25 | Abbott Diabetes Care Inc. | Analyte sensor with time lag compensation |
US7610086B1 (en) | 2006-03-31 | 2009-10-27 | Pacesetter, Inc. | System and method for detecting cardiac ischemia in real-time using a pattern classifier implemented within an implanted medical device |
US7653425B2 (en) | 2006-08-09 | 2010-01-26 | Abbott Diabetes Care Inc. | Method and system for providing calibration of an analyte sensor in an analyte monitoring system |
US8126538B2 (en) * | 2006-06-06 | 2012-02-28 | Cardiac Pacemakers, Inc. | Method and apparatus for introducing endolymphatic instrumentation |
US8206296B2 (en) | 2006-08-07 | 2012-06-26 | Abbott Diabetes Care Inc. | Method and system for providing integrated analyte monitoring and infusion system therapy management |
US8932216B2 (en) | 2006-08-07 | 2015-01-13 | Abbott Diabetes Care Inc. | Method and system for providing data management in integrated analyte monitoring and infusion system |
US20080058881A1 (en) * | 2006-09-01 | 2008-03-06 | Cardiac Pacemakers, Inc | Method and system for treating post-mi patients |
US8108035B1 (en) | 2006-10-18 | 2012-01-31 | Pacesetter, Inc. | Systems and methods for detecting and compensating for changes in posture during ischemia detection a using an implantable medical device |
US8155731B1 (en) | 2006-10-18 | 2012-04-10 | Pacesetter, Inc. | Systems and methods for detecting and compensating for changes in posture during ischemia detection using an implantable medical device |
JP2010508091A (en) | 2006-10-26 | 2010-03-18 | アボット ダイアベティス ケア インコーポレイテッド | Method, system, and computer program product for detecting in real time a decrease in sensitivity of an analyte sensor |
US8600499B2 (en) * | 2006-12-05 | 2013-12-03 | Cardiac Pacemakers, Inc. | Method and device for cardiac vasoactive therapy |
US8265739B1 (en) | 2007-01-19 | 2012-09-11 | Pacesetter, Inc. | Systems and methods for distinguishing cardiac ischemia from systemic influences on IEGM morphology using an implantable medical device |
US7894884B2 (en) * | 2007-01-31 | 2011-02-22 | Medtronic, Inc. | System and method for ischemia classification with implantable medical device |
US8798723B2 (en) * | 2007-01-31 | 2014-08-05 | Medtronic, Inc. | System and method for ischemia classification with implantable medical device |
US8275463B1 (en) | 2007-02-01 | 2012-09-25 | Pacesetter, Inc. | Recording a context for sensed biological data |
US20080199894A1 (en) | 2007-02-15 | 2008-08-21 | Abbott Diabetes Care, Inc. | Device and method for automatic data acquisition and/or detection |
US8123686B2 (en) | 2007-03-01 | 2012-02-28 | Abbott Diabetes Care Inc. | Method and apparatus for providing rolling data in communication systems |
US8615296B2 (en) | 2007-03-06 | 2013-12-24 | Cardiac Pacemakers, Inc. | Method and apparatus for closed-loop intermittent cardiac stress augmentation pacing |
EP2143045A1 (en) * | 2007-03-14 | 2010-01-13 | Spectros Corporation | Metabolism-or biochemical-based anti-spoofing biometrics devices, systems, and methods |
US7949388B1 (en) | 2007-03-16 | 2011-05-24 | Pacesetter, Inc. | Methods and systems to characterize ST segment variation over time |
CA2683953C (en) | 2007-04-14 | 2016-08-02 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in medical communication system |
ES2817503T3 (en) | 2007-04-14 | 2021-04-07 | Abbott Diabetes Care Inc | Procedure and apparatus for providing data processing and control in a medical communication system |
WO2008130895A2 (en) | 2007-04-14 | 2008-10-30 | Abbott Diabetes Care, Inc. | Method and apparatus for providing dynamic multi-stage signal amplification in a medical device |
US9615780B2 (en) | 2007-04-14 | 2017-04-11 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in medical communication system |
WO2008130898A1 (en) | 2007-04-14 | 2008-10-30 | Abbott Diabetes Care, Inc. | Method and apparatus for providing data processing and control in medical communication system |
US8461985B2 (en) | 2007-05-08 | 2013-06-11 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8456301B2 (en) | 2007-05-08 | 2013-06-04 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8665091B2 (en) | 2007-05-08 | 2014-03-04 | Abbott Diabetes Care Inc. | Method and device for determining elapsed sensor life |
US7928850B2 (en) | 2007-05-08 | 2011-04-19 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8560038B2 (en) | 2007-05-14 | 2013-10-15 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US9125548B2 (en) | 2007-05-14 | 2015-09-08 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8444560B2 (en) | 2007-05-14 | 2013-05-21 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8600681B2 (en) | 2007-05-14 | 2013-12-03 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US10002233B2 (en) | 2007-05-14 | 2018-06-19 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8239166B2 (en) | 2007-05-14 | 2012-08-07 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8103471B2 (en) | 2007-05-14 | 2012-01-24 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8260558B2 (en) | 2007-05-14 | 2012-09-04 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
DE102007025664B4 (en) * | 2007-06-01 | 2016-11-10 | Masimo Corp. | Method for automatically registering a subject's physical performance |
US7769436B1 (en) | 2007-06-04 | 2010-08-03 | Pacesetter, Inc. | System and method for adaptively adjusting cardiac ischemia detection thresholds and other detection thresholds used by an implantable medical device |
JP2010531169A (en) * | 2007-06-21 | 2010-09-24 | アボット ダイアベティス ケア インコーポレイテッド | Health monitoring device |
AU2008265541B2 (en) | 2007-06-21 | 2014-07-17 | Abbott Diabetes Care, Inc. | Health management devices and methods |
AU2013205279B2 (en) * | 2007-06-21 | 2015-09-24 | Abbott Diabetes Care Inc. | Health monitor |
US8160900B2 (en) | 2007-06-29 | 2012-04-17 | Abbott Diabetes Care Inc. | Analyte monitoring and management device and method to analyze the frequency of user interaction with the device |
CN100571612C (en) * | 2007-07-13 | 2009-12-23 | 深圳迪美泰数字医学技术有限公司 | The pure digital medical amplifier that is used for clinical or non-clinical bio signal record |
US8834366B2 (en) | 2007-07-31 | 2014-09-16 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor calibration |
US7865232B1 (en) | 2007-08-07 | 2011-01-04 | Pacesetter, Inc. | Method and system for automatically calibrating ischemia detection parameters |
US8019410B1 (en) | 2007-08-22 | 2011-09-13 | Pacesetter, Inc. | System and method for detecting hypoglycemia using an implantable medical device based on pre-symptomatic physiological responses |
WO2009037748A1 (en) * | 2007-09-19 | 2009-03-26 | Drug Safety Testing Center Co., Ltd. | Safety pharmacological test method |
US8469897B2 (en) * | 2007-10-15 | 2013-06-25 | Pacesetter, Inc. | Method and system for tracking quality of life in patients with angina |
US8377031B2 (en) | 2007-10-23 | 2013-02-19 | Abbott Diabetes Care Inc. | Closed loop control system with safety parameters and methods |
US8409093B2 (en) | 2007-10-23 | 2013-04-02 | Abbott Diabetes Care Inc. | Assessing measures of glycemic variability |
US8216138B1 (en) | 2007-10-23 | 2012-07-10 | Abbott Diabetes Care Inc. | Correlation of alternative site blood and interstitial fluid glucose concentrations to venous glucose concentration |
US8204592B1 (en) | 2007-12-03 | 2012-06-19 | Pacesetter, Inc. | System and method for generating and using cardiac ischemia diagnostics based on arrhythmia precursors and arrhythmia episodes |
US20090164239A1 (en) | 2007-12-19 | 2009-06-25 | Abbott Diabetes Care, Inc. | Dynamic Display Of Glucose Information |
EP2254660A1 (en) | 2008-01-29 | 2010-12-01 | Cardiac Pacemakers, Inc. | Configurable intermittent pacing therapy |
US8483826B2 (en) | 2008-03-17 | 2013-07-09 | Cardiac Pacemakers, Inc. | Deactivation of intermittent pacing therapy |
US20090275996A1 (en) * | 2008-04-30 | 2009-11-05 | Medtronic, Inc. | Techniques for placing medical leads for electrical stimulation of nerve tissue |
US7826382B2 (en) | 2008-05-30 | 2010-11-02 | Abbott Diabetes Care Inc. | Close proximity communication device and methods |
US8924159B2 (en) | 2008-05-30 | 2014-12-30 | Abbott Diabetes Care Inc. | Method and apparatus for providing glycemic control |
US8591410B2 (en) | 2008-05-30 | 2013-11-26 | Abbott Diabetes Care Inc. | Method and apparatus for providing glycemic control |
US8876755B2 (en) | 2008-07-14 | 2014-11-04 | Abbott Diabetes Care Inc. | Closed loop control system interface and methods |
US20100057158A1 (en) * | 2008-08-26 | 2010-03-04 | Pacesetter, Inc. | Neurostimulation Based On Glycemic Condition |
US8622988B2 (en) | 2008-08-31 | 2014-01-07 | Abbott Diabetes Care Inc. | Variable rate closed loop control and methods |
US9943644B2 (en) | 2008-08-31 | 2018-04-17 | Abbott Diabetes Care Inc. | Closed loop control with reference measurement and methods thereof |
US8734422B2 (en) | 2008-08-31 | 2014-05-27 | Abbott Diabetes Care Inc. | Closed loop control with improved alarm functions |
US20100057040A1 (en) | 2008-08-31 | 2010-03-04 | Abbott Diabetes Care, Inc. | Robust Closed Loop Control And Methods |
US8986208B2 (en) | 2008-09-30 | 2015-03-24 | Abbott Diabetes Care Inc. | Analyte sensor sensitivity attenuation mitigation |
WO2010051500A1 (en) * | 2008-10-31 | 2010-05-06 | Medtronic, Inc. | Therapy system including cardiac rhythm therapy and neurostimulation capabilities |
US8249708B2 (en) * | 2008-10-31 | 2012-08-21 | Medtronic, Inc. | Implantable medical device crosstalk evaluation and mitigation |
US8452394B2 (en) | 2008-10-31 | 2013-05-28 | Medtronic, Inc. | Implantable medical device crosstalk evaluation and mitigation |
US8498698B2 (en) | 2008-10-31 | 2013-07-30 | Medtronic, Inc. | Isolation of sensing and stimulation circuitry |
US8688210B2 (en) * | 2008-10-31 | 2014-04-01 | Medtronic, Inc. | Implantable medical device crosstalk evaluation and mitigation |
US8532779B2 (en) * | 2008-10-31 | 2013-09-10 | Medtronic, Inc. | Implantable medical device crosstalk evaluation and mitigation |
US9192769B2 (en) * | 2008-10-31 | 2015-11-24 | Medtronic, Inc. | Shunt-current reduction techniques for an implantable therapy system |
US8774918B2 (en) * | 2008-10-31 | 2014-07-08 | Medtronic, Inc. | Implantable medical device crosstalk evaluation and mitigation |
US8611996B2 (en) | 2008-10-31 | 2013-12-17 | Medtronic, Inc. | Implantable medical device crosstalk evaluation and mitigation |
US9301698B2 (en) | 2008-10-31 | 2016-04-05 | Medtronic, Inc. | Method and apparatus to detect ischemia with a pressure sensor |
US8005539B2 (en) * | 2008-10-31 | 2011-08-23 | Medtronic, Inc. | Implantable medical device crosstalk evaluation and mitigation |
US8560060B2 (en) | 2008-10-31 | 2013-10-15 | Medtronic, Inc. | Isolation of sensing and stimulation circuitry |
EP2367596A1 (en) * | 2008-10-31 | 2011-09-28 | Medtronic, Inc. | Shunt-current reduction housing for an implantable therapy system |
US9597505B2 (en) * | 2008-10-31 | 2017-03-21 | Medtronic, Inc. | Implantable medical device crosstalk evaluation and mitigation |
US9775987B2 (en) | 2008-10-31 | 2017-10-03 | Medtronic, Inc. | Implantable medical device crosstalk evaluation and mitigation |
US8260412B2 (en) | 2008-10-31 | 2012-09-04 | Medtronic, Inc. | Implantable medical device crosstalk evaluation and mitigation |
US9801575B2 (en) | 2011-04-15 | 2017-10-31 | Dexcom, Inc. | Advanced analyte sensor calibration and error detection |
US9326707B2 (en) | 2008-11-10 | 2016-05-03 | Abbott Diabetes Care Inc. | Alarm characterization for analyte monitoring devices and systems |
US8527068B2 (en) | 2009-02-02 | 2013-09-03 | Nanostim, Inc. | Leadless cardiac pacemaker with secondary fixation capability |
US9402544B2 (en) | 2009-02-03 | 2016-08-02 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
US8630692B2 (en) | 2009-04-30 | 2014-01-14 | Pacesetter, Inc. | Method and implantable system for blood-glucose concentration monitoring using parallel methodologies |
US8497777B2 (en) | 2009-04-15 | 2013-07-30 | Abbott Diabetes Care Inc. | Analyte monitoring system having an alert |
EP2419015A4 (en) | 2009-04-16 | 2014-08-20 | Abbott Diabetes Care Inc | Analyte sensor calibration management |
US9226701B2 (en) | 2009-04-28 | 2016-01-05 | Abbott Diabetes Care Inc. | Error detection in critical repeating data in a wireless sensor system |
US8368556B2 (en) | 2009-04-29 | 2013-02-05 | Abbott Diabetes Care Inc. | Method and system for providing data communication in continuous glucose monitoring and management system |
US8483967B2 (en) | 2009-04-29 | 2013-07-09 | Abbott Diabetes Care Inc. | Method and system for providing real time analyte sensor calibration with retrospective backfill |
US8983600B2 (en) | 2009-05-15 | 2015-03-17 | Cardiac Pacemakers, Inc. | Method and apparatus for safety control during cardiac pacing mode transition |
US8958873B2 (en) | 2009-05-28 | 2015-02-17 | Cardiac Pacemakers, Inc. | Method and apparatus for safe and efficient delivery of cardiac stress augmentation pacing |
WO2010138856A1 (en) | 2009-05-29 | 2010-12-02 | Abbott Diabetes Care Inc. | Medical device antenna systems having external antenna configurations |
EP4289355A3 (en) | 2009-07-23 | 2024-02-28 | Abbott Diabetes Care Inc. | Continuous analyte measurement system |
DK3173014T3 (en) | 2009-07-23 | 2021-09-13 | Abbott Diabetes Care Inc | Real-time control of data on physiological control of glucose levels |
WO2011014851A1 (en) | 2009-07-31 | 2011-02-03 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte monitoring system calibration accuracy |
US9314195B2 (en) | 2009-08-31 | 2016-04-19 | Abbott Diabetes Care Inc. | Analyte signal processing device and methods |
EP4070728A1 (en) | 2009-08-31 | 2022-10-12 | Abbott Diabetes Care, Inc. | Displays for a medical device |
EP2473099A4 (en) | 2009-08-31 | 2015-01-14 | Abbott Diabetes Care Inc | Analyte monitoring system and methods for managing power and noise |
AU2010286917B2 (en) | 2009-08-31 | 2016-03-10 | Abbott Diabetes Care Inc. | Medical devices and methods |
US8812104B2 (en) | 2009-09-23 | 2014-08-19 | Cardiac Pacemakers, Inc. | Method and apparatus for automated control of pacing post-conditioning |
US20110071413A1 (en) * | 2009-09-24 | 2011-03-24 | Yi Zhang | Morphology based ischemia detection using intracardiac electrograms |
EP2493560A1 (en) | 2009-10-30 | 2012-09-05 | Cardiac Pacemakers, Inc. | Pacemaker with vagal surge monitoring and response |
EP2494323A4 (en) | 2009-10-30 | 2014-07-16 | Abbott Diabetes Care Inc | Method and apparatus for detecting false hypoglycemic conditions |
US8635046B2 (en) | 2010-06-23 | 2014-01-21 | Abbott Diabetes Care Inc. | Method and system for evaluating analyte sensor response characteristics |
US10092229B2 (en) | 2010-06-29 | 2018-10-09 | Abbott Diabetes Care Inc. | Calibration of analyte measurement system |
EP2624745A4 (en) | 2010-10-07 | 2018-05-23 | Abbott Diabetes Care, Inc. | Analyte monitoring devices and methods |
US9060692B2 (en) | 2010-10-12 | 2015-06-23 | Pacesetter, Inc. | Temperature sensor for a leadless cardiac pacemaker |
WO2012051237A1 (en) | 2010-10-12 | 2012-04-19 | Nanostim, Inc. | Temperature sensor for a leadless cardiac pacemaker |
JP2013540022A (en) | 2010-10-13 | 2013-10-31 | ナノスティム・インコーポレイテッド | Leadless cardiac pacemaker with screw anti-rotation element |
US8688200B2 (en) | 2010-10-29 | 2014-04-01 | Medtronic, Inc. | Ischemia detection and classification |
EP2651494B1 (en) | 2010-12-13 | 2017-02-15 | Pacesetter, Inc. | Delivery catheter |
EP3090779B1 (en) | 2010-12-13 | 2017-11-08 | Pacesetter, Inc. | Pacemaker retrieval systems |
EP2654889B1 (en) | 2010-12-20 | 2017-03-01 | Pacesetter, Inc. | Leadless pacemaker with radial fixation mechanism |
CA3177983A1 (en) | 2011-02-28 | 2012-11-15 | Abbott Diabetes Care Inc. | Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same |
US10136845B2 (en) | 2011-02-28 | 2018-11-27 | Abbott Diabetes Care Inc. | Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same |
US8649852B2 (en) | 2011-05-02 | 2014-02-11 | Medtronic, Inc. | Method of signal enhancement for ECG devices |
US8989852B2 (en) | 2011-08-10 | 2015-03-24 | Pacesetter, Inc. | Systems and methods for use by implantable medical devices for detecting and discriminating stroke and cardiac ischemia using electrocardiac signals |
WO2013066873A1 (en) | 2011-10-31 | 2013-05-10 | Abbott Diabetes Care Inc. | Electronic devices having integrated reset systems and methods thereof |
US9622691B2 (en) | 2011-10-31 | 2017-04-18 | Abbott Diabetes Care Inc. | Model based variable risk false glucose threshold alarm prevention mechanism |
US9511236B2 (en) | 2011-11-04 | 2016-12-06 | Pacesetter, Inc. | Leadless cardiac pacemaker with integral battery and redundant welds |
US9317656B2 (en) | 2011-11-23 | 2016-04-19 | Abbott Diabetes Care Inc. | Compatibility mechanisms for devices in a continuous analyte monitoring system and methods thereof |
US8710993B2 (en) | 2011-11-23 | 2014-04-29 | Abbott Diabetes Care Inc. | Mitigating single point failure of devices in an analyte monitoring system and methods thereof |
WO2013078426A2 (en) | 2011-11-25 | 2013-05-30 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods of use |
WO2014022661A1 (en) | 2012-08-01 | 2014-02-06 | Nanostim, Inc. | Biostimulator circuit with flying cell |
EP3395252A1 (en) | 2012-08-30 | 2018-10-31 | Abbott Diabetes Care, Inc. | Dropout detection in continuous analyte monitoring data during data excursions |
US9968306B2 (en) | 2012-09-17 | 2018-05-15 | Abbott Diabetes Care Inc. | Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems |
EP2901153A4 (en) | 2012-09-26 | 2016-04-27 | Abbott Diabetes Care Inc | Method and apparatus for improving lag correction during in vivo measurement of analyte concentration with analyte concentration variability and range data |
US10433773B1 (en) | 2013-03-15 | 2019-10-08 | Abbott Diabetes Care Inc. | Noise rejection methods and apparatus for sparsely sampled analyte sensor data |
US9474475B1 (en) | 2013-03-15 | 2016-10-25 | Abbott Diabetes Care Inc. | Multi-rate analyte sensor data collection with sample rate configurable signal processing |
US10076285B2 (en) | 2013-03-15 | 2018-09-18 | Abbott Diabetes Care Inc. | Sensor fault detection using analyte sensor data pattern comparison |
US10736516B2 (en) | 2013-11-21 | 2020-08-11 | Medtronic, Inc. | Method and apparatus for accurately determining heart rate variability and sympathetic reserve |
US20170185748A1 (en) | 2014-03-30 | 2017-06-29 | Abbott Diabetes Care Inc. | Method and Apparatus for Determining Meal Start and Peak Events in Analyte Monitoring Systems |
US9782092B2 (en) | 2014-11-14 | 2017-10-10 | Siemens Medical Solutions Usa, Inc. | Patient signal analysis based on vector analysis |
AU2016291569B2 (en) | 2015-07-10 | 2021-07-08 | Abbott Diabetes Care Inc. | System, device and method of dynamic glucose profile response to physiological parameters |
WO2018175489A1 (en) | 2017-03-21 | 2018-09-27 | Abbott Diabetes Care Inc. | Methods, devices and system for providing diabetic condition diagnosis and therapy |
US11331022B2 (en) | 2017-10-24 | 2022-05-17 | Dexcom, Inc. | Pre-connected analyte sensors |
US20190120785A1 (en) | 2017-10-24 | 2019-04-25 | Dexcom, Inc. | Pre-connected analyte sensors |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2755643A1 (en) * | 1977-12-14 | 1979-06-21 | Zeiss Carl Fa | PROCEDURE AND ARRANGEMENT FOR ELECTRONIC LONG-TERM HEART MONITORING |
DE2816494B2 (en) * | 1978-04-15 | 1981-05-27 | Collectron Systems AG, Effretikon | Device for recording physiological measured values |
US4210149A (en) * | 1978-04-17 | 1980-07-01 | Mieczyslaw Mirowski | Implantable cardioverter with patient communication |
US4223678A (en) * | 1978-05-03 | 1980-09-23 | Mieczyslaw Mirowski | Arrhythmia recorder for use with an implantable defibrillator |
US4481950A (en) * | 1979-04-27 | 1984-11-13 | Medtronic, Inc. | Acoustic signalling apparatus for implantable devices |
US4681117A (en) * | 1983-02-15 | 1987-07-21 | Brodman Richard F | Intracardiac catheter and a method for detecting myocardial ischemia |
US4562846A (en) * | 1983-09-15 | 1986-01-07 | Duke University | System and process for monitoring myocardial integrity |
US4586508A (en) * | 1984-03-23 | 1986-05-06 | Cordis Corporation | Implant communication system with patient coil |
US4679144A (en) * | 1984-08-21 | 1987-07-07 | Q-Med, Inc. | Cardiac signal real time monitor and method of analysis |
US4546776A (en) * | 1984-09-13 | 1985-10-15 | Bellin Howard T | Portable EKG monitoring device for ST deviation |
US4625730A (en) * | 1985-04-09 | 1986-12-02 | The Johns Hopkins University | Patient ECG recording control for an automatic implantable defibrillator |
IT1182540B (en) * | 1985-07-25 | 1987-10-05 | Paolo Rossi | EQUIPMENT WITH AN IMPLANTABLE PART IN THE SUBCUTE FOR THE CONTINUOUS DETECTION OF CARDIOR-EXPIRATORY PHYSIOLOGICAL VARIABLES |
US5003983A (en) * | 1988-08-25 | 1991-04-02 | Cortec, Inc. | Cardiac monitoring system |
FR2645005A1 (en) * | 1988-12-30 | 1990-10-05 | Scalisi Gerard | Method and devices for recording in succession a reference electrocardiogram then a second electrocardiogram for the same patient and for comparing them |
JPH02286128A (en) * | 1989-04-27 | 1990-11-26 | Terumo Corp | Electrocardiograph |
US5113869A (en) * | 1990-08-21 | 1992-05-19 | Telectronics Pacing Systems, Inc. | Implantable ambulatory electrocardiogram monitor |
-
1991
- 1991-03-12 US US07/667,819 patent/US5135004A/en not_active Expired - Lifetime
-
1992
- 1992-03-10 AU AU15552/92A patent/AU641891B2/en not_active Expired
- 1992-03-10 CA CA002080460A patent/CA2080460C/en not_active Expired - Fee Related
- 1992-03-10 EP EP92908265A patent/EP0529055B1/en not_active Expired - Lifetime
- 1992-03-10 WO PCT/US1992/001880 patent/WO1992016143A1/en active IP Right Grant
- 1992-03-10 ES ES92908265T patent/ES2101841T3/en not_active Expired - Lifetime
- 1992-03-10 JP JP50786992A patent/JP3237844B2/en not_active Expired - Lifetime
- 1992-03-10 AT AT92908265T patent/ATE152897T1/en not_active IP Right Cessation
- 1992-03-10 DE DE69219698T patent/DE69219698T2/en not_active Expired - Lifetime
- 1992-03-10 DK DK92908265.9T patent/DK0529055T3/en active
-
1997
- 1997-06-30 GR GR970401579T patent/GR3023931T3/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2080460A1 (en) | 1992-09-13 |
AU641891B2 (en) | 1993-09-30 |
EP0529055A1 (en) | 1993-03-03 |
AU1555292A (en) | 1992-10-21 |
GR3023931T3 (en) | 1997-09-30 |
DE69219698T2 (en) | 1998-01-02 |
WO1992016143A1 (en) | 1992-10-01 |
JP3237844B2 (en) | 2001-12-10 |
DK0529055T3 (en) | 1997-12-01 |
US5135004A (en) | 1992-08-04 |
ATE152897T1 (en) | 1997-05-15 |
ES2101841T3 (en) | 1997-07-16 |
DE69219698D1 (en) | 1997-06-19 |
JPH05506600A (en) | 1993-09-30 |
EP0529055B1 (en) | 1997-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2080460C (en) | Myocardial ischemia monitor and related method | |
US8024028B2 (en) | Cardiac event detection over varying time scale | |
EP1400259B1 (en) | System for the detection of cardiac events | |
US5560369A (en) | Cardiac arrhythmia detection system for an implantable stimulation device and method | |
JP3325941B2 (en) | Non-intrusive multi-electrocardiographic device for assessing acute ischemic injury | |
US5718242A (en) | Cardiac arrhythmia detection system for an implantable stimulation device and method | |
US5312446A (en) | Compressed storage of data in cardiac pacemakers | |
US8655434B2 (en) | Physician's programmer with ST-segment histogram display capability | |
EP0268708B1 (en) | Apparatus for recognising rejection of transplanted hearts | |
US7181269B1 (en) | Implantable device that diagnoses ischemia and myocardial infarction and method | |
US7286872B2 (en) | Method and apparatus for managing data from multiple sensing channels | |
JP2007516816A (en) | Distributed cardiac activity monitoring with selective filtering | |
US8241221B2 (en) | Systems and methods for use with an implantable medical device for detecting stroke based on electrocardiac signals | |
JP2005177458A (en) | Electrogram signal filtering in system for detecting ischemia | |
JPH11507556A (en) | Data Reduction Method of Detected Value in Implantable Therapy Device Using Variable Resolution Technology | |
US6385485B1 (en) | Continuously monitoring cardiac events in an active implantable medical device | |
EP1427335B1 (en) | Automatic threshold generation for electrogram measurement |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |